Author

S. S. Chatterjee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

H. F. Chambers· 2 shared L. Huang· 2 shared L.-Y. Lai· 2 shared N. Mukkayyan· 2 shared N. Satishkumar· 2 shared R. Poon· 2 shared A. Arruda· 1 shared A. Bose· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. F. Chambers

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus

L.-Y. Lai, N. Satishkumar, S. Cardozo, V. Hemmadi, L. B. Marques, L. Huang, S. R. Filipe, M. G. Pinho, H. F. Chambers, S. S. Chatterjee

This study identifies that mutations in PBP4 and GdpP synergistically confer high-level, broad-spectrum β-lactam resistance in mecA-deficient Staphylococcus aureus strains.

bioRxiv · Oct 26, 2023 · PreprintMicrobiology

KDM6A loss sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition

L. D. Boila, S. Ghosh, S. K. Bandyopadhyay, L. Jin, A. Murison, A. G. X. Zeng, W. Shaikh, S. Bhowmik, S. S. N. A. Muddineni, M. Biswas, S. Sinha, S. S. Chatterjee, N. Mbong, O. I. Gan, A. Bose, , A. Sengupta

This study shows that KDM6A loss in AML increases sensitivity to PARP and BCL2 inhibitors, suggesting a new combination therapy approach for KDM6A-mutant AML.

bioRxiv · Jul 12, 2022 · PreprintCancer Biology

In-vivo detection of cyclic-di-AMP in Staphylococcus aureus

N. Mukkayyan, R. Poon, P. Sander, L.-Y. Lai, Z. Zubair-Nizami, M. Hammond, S. S. Chatterjee

This study develops a biosensor for in-vivo detection of cyclic-di-AMP in Staphylococcus aureus, showing its ability to detect a wide concentration range in both laboratory and clinical strains.

bioRxiv · May 16, 2022Microbiology

Loss of GdpP function in Staphylococcus aureus leads to β-lactam tolerance and enhanced evolution of β-lactam resistance

R. Poon, L. Basuino, N. Satishkumar, A. Chatterjee, N. Mukkayyan, E. Buggeln, L. Huang, V. Nair, M. A. Argudin, S. K. Datta, H. F. Chambers, S. S. Chatterjee

This study shows that loss of GdpP function in Staphylococcus aureus increases β-lactam tolerance and facilitates the evolution of β-lactam resistance.

bioRxiv · Jul 2, 2021Microbiology